Powered by

WellDoc Closes $20 Million in Strategic Financing

Jan 10, 2014 - Business Wire

WellDoc ®, developers of the first FDA cleared mobile prescription therapy, BlueStar TM, announced today that it received funding from its first institutional investors, Merck Global Health Innovation Fund and Windham Venture Partners, as part of a $20M round of financing that now broadens its capitalization beyond its initial group of angel investors. For a limited time, WellDoc and its investors will also explore the possibility of adding co-investors that bring strategic value to the company...